drugset / Trial / NCT00775918

Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions

NCT00775918

Completed 32 enrolled Ranbaxy Laboratories Limited
RandomizedCrossoverOpen-label

Summary

The purpose of this study was to determine the bioequivalence of Doxycycline monohydrate formulations after administration of single doses to normal healthy subjects under fed conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.

Timeline

Start
2005-06
Primary completion
2005-06
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg

Indications

No indication recorded.